Merck prevails in Gardasil safety litigation
A federal judge has ruled in favor of Merck in litigation accusing the drugmaker of concealing the risks of Gardasil, a ...
Merck opens manufacturing facility in North Carolina amid Trump's tariff threats
Merck said on Tuesday it has opened a new $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its ...
DelveInsight Business Research, LLP: BAVENCIO Continues to Strengthen Its Position in the Immuno-Oncology Landscape | DelveInsight
With the rising adoption of checkpoint inhibitors and combination therapies, BAVENCIO's market growth is driven by expanding indications and strategic partnerships. However, competition from ...
BAVENCIO Continues to Strengthen Its Position in the Immuno-Oncology Landscape | DelveInsight
DelveInsight's "BAVENCIO Market Size, Forecast, and Market Insight Report" highlights the details around BAVENCIO, a human ...
DelveInsight Business Research, LLP: TEPMETKO Continues to Strengthens its Position as a Leading METex14 Skipping NSCLC Therapy | DelveInsight
With increasing biomarker-driven cancer treatments, TEPMETKO benefits from growing adoption in precision oncology. Competition from other MET inhibitors like TABRECTA (capmatinib) exists, but ...